These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 4063965

  • 21. [Enhanced effect of intraperitoneal administration of CDDP combined with caffeine against peritoneal metastasis].
    Yamamoto Y, Amano T, Imada T, Akaike M, Noguchi Y, Aoyama N, Tsuburaya A, Rino Y, Takehana T, Hasuo K.
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1825-31. PubMed ID: 1877825
    [Abstract] [Full Text] [Related]

  • 22. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ, Tian H, Joseph IB, Menon K, Frost D.
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [Abstract] [Full Text] [Related]

  • 23. Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin.
    Goto H, Yano S, Matsumori Y, Ogawa H, Blakey DC, Sone S.
    Clin Cancer Res; 2004 Nov 15; 10(22):7671-6. PubMed ID: 15570000
    [Abstract] [Full Text] [Related]

  • 24. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma.
    Chahinian AP, Norton L, Holland JF, Szrajer L, Hart RD.
    Cancer Res; 1984 Apr 15; 44(4):1688-92. PubMed ID: 6423278
    [Abstract] [Full Text] [Related]

  • 25. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M, Barrier A, Valinas R, Flahault A, Adloff M, Pezet D, Jaeck D, Millat B, French University Association for Surgical Research.
    Hepatogastroenterology; 2001 Apr 15; 48(39):875-8. PubMed ID: 11462946
    [Abstract] [Full Text] [Related]

  • 26. Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine.
    Greco WR, Park HS, Rustum YM.
    Cancer Res; 1990 Sep 01; 50(17):5318-27. PubMed ID: 2386940
    [Abstract] [Full Text] [Related]

  • 27. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
    Hirokawa Y, Levitzki A, Lessene G, Baell J, Xiao Y, Zhu H, Maruta H.
    Cancer Lett; 2007 Jan 08; 245(1-2):242-51. PubMed ID: 16540233
    [Abstract] [Full Text] [Related]

  • 28. Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.
    Iwakawa M, Tofilon PJ, Arundel C, Milas L.
    Cancer Res; 1989 Apr 01; 49(7):1640-3. PubMed ID: 2924311
    [Abstract] [Full Text] [Related]

  • 29. Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin.
    Ghamande S, Hylander BL, Oflazoglu E, Lele S, Fanslow W, Repasky EA.
    Cancer Res; 2001 Oct 15; 61(20):7556-62. PubMed ID: 11606394
    [Abstract] [Full Text] [Related]

  • 30. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
    Schiller JH, Bittner G.
    Clin Cancer Res; 1999 Dec 15; 5(12):4287-94. PubMed ID: 10632372
    [Abstract] [Full Text] [Related]

  • 31. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F, Duivenvoorden WC, Singh G.
    Anticancer Drugs; 2009 Feb 15; 20(2):115-22. PubMed ID: 19209028
    [Abstract] [Full Text] [Related]

  • 32. Re: W. R. Greco et al., Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res., 50: 5318-5327, 1990.
    Berenbaum MC.
    Cancer Res; 1992 Aug 15; 52(16):4558-60; author reply 4561-5. PubMed ID: 1643648
    [No Abstract] [Full Text] [Related]

  • 33. Re: W. R. Greco et al., Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res., 50: 5318-5327, 1990.
    Sühnel J.
    Cancer Res; 1992 Aug 15; 52(16):4560-1; author reply 4561-5. PubMed ID: 1643649
    [No Abstract] [Full Text] [Related]

  • 34. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S.
    Cancer Res; 2008 Oct 01; 68(19):7956-65. PubMed ID: 18829553
    [Abstract] [Full Text] [Related]

  • 35. Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents.
    Knecht R, Peters S, Adunka O, Strebhardt K, Gstoettner W, Hambek M.
    Anticancer Res; 2003 Oct 01; 23(3B):2577-83. PubMed ID: 12894544
    [Abstract] [Full Text] [Related]

  • 36. An experimental study on the therapeutic effect of consecutive low-dose cisplatin with caffeine in sarcoma-bearing mice.
    Takeda A, Tsuchiya H, Tajino T, Kikuchi S.
    Anticancer Res; 2005 Oct 01; 25(4):2777-84. PubMed ID: 16080526
    [Abstract] [Full Text] [Related]

  • 37. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
    Bergerat JP, Drewinko B, Corry P, Barlogie B, Ho DH.
    Cancer Res; 1981 Jan 01; 41(1):25-30. PubMed ID: 7192598
    [Abstract] [Full Text] [Related]

  • 38. Chemotherapy of human yolk sac tumor heterotransplanted in nude mice.
    Sawada M, Matsui Y, Okudaira Y.
    J Natl Cancer Inst; 1983 Dec 01; 71(6):1221-5. PubMed ID: 6197552
    [Abstract] [Full Text] [Related]

  • 39. Mitomycin C and cisplatin increase survival in a human pancreatic cancer metastatic model.
    Tomikawa M, Kubota T, Matsuzaki SW, Takahasi S, Kitajima M, Moosa AR, Hoffman RM.
    Anticancer Res; 1997 Dec 01; 17(5A):3623-5. PubMed ID: 9413214
    [Abstract] [Full Text] [Related]

  • 40. Chemotherapy of murine colorectal carcinoma with cisplatin and cisplatin plus 3'-deoxy-3'-azidothymidine.
    Klann RC, Holbrook CT, Nyce JW.
    Anticancer Res; 1992 Dec 01; 12(3):781-7. PubMed ID: 1535769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.